Skip to content

General Discussion

A place to talk about whatever you want

2 Topics 3 Posts
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
  • Clarification on indication inclusion in multi-Product APS

    2
    0 Votes
    2 Posts
    19 Views
    Jennifer CarrollJ
    Good Morning @Supriya We assume that you are referring to a patient targeted APS. As a patient would not have a prescription for all the products, this would contravene the direct-to-consumer advertising (DTCA) regulations (Section C.01.044 of the Food and Drugs Act Regulations) to create a link to the therapeutic use (i.e. indication could not be included) for products they are not prescribed. While the three base levels of fair balance apply only to HCP-targeted APS, a weblink to the Terms of Market Authorization (TMA) links the therapeutic use, a violation of the DTCA regulations.
  • Welcome to your NodeBB!

    1
    0 Votes
    1 Posts
    46 Views
    No one has replied
  • Healthcare Professional Tour

    1
    0 Votes
    1 Posts
    17k Views
    No one has replied
  • Industry Tour

    1
    0 Votes
    1 Posts
    7k Views
    No one has replied
  • Patient Tour

    1
    0 Votes
    1 Posts
    2k Views
    No one has replied
  • This topic is deleted!

    1
    0 Votes
    1 Posts
    100 Views
    No one has replied